We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+23.21%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$99.5M
AUM Growth
+$4.62M
(+4.9%)
Cap. Flow
-$4.26M
Cap. Flow
% of AUM
-4.28%
Top 10 Holdings %
Top 10 Hldgs %
44.59%
Holding
87
New
5
Increased
10
Reduced
44
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Inogen
INGN
|
+$996K |
| 2 |
NeuroOne Medical Technologies
NMTC
|
+$923K |
| 3 |
Ondas Inc
ONDS
|
+$831K |
| 4 |
Perion Network
PERI
|
+$700K |
| 5 |
MDxHealth
MDXH
|
+$447K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTLP
Cantaloupe
CTLP
|
+$1.85M |
| 2 |
Exagen
XGN
|
+$1.16M |
| 3 |
Village Farms International
VFF
|
+$798K |
| 4 |
Natera
NTRA
|
+$635K |
| 5 |
Fastenal
FAST
|
+$394K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 57.43% |
| 2 | Technology | 23.96% |
| 3 | Communication Services | 10.24% |
| 4 | Industrials | 4.64% |
| 5 | Consumer Staples | 2.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
NeoGenomics
NEO
$1.96B
| $1.23M | 1.23% |
167,950
-11,600
| -6% | -$93.6K |
|
27
Vericel Corp
VCEL
$2.35B
| $1.11M | 1.12% |
26,100
-500
| -2% | -$20.8K |
|
28
AbbVie
ABBV
$443B
| $1.09M | 1.1% |
5,892
-338
| -5% | -$62.8K |
|
|
29
Inogen
INGN
$175M
| $1.04M | 1.05% |
+148,050
| New | +$996K |
|
30
Crexendo
CXDO
$223M
| $1.04M | 1.04% |
170,600
| – | – |
|
|
31
NeuroOne Medical Technologies
NMTC
$14.7M
| $1.02M | 1.02% |
+250,000
| New | +$923K |
|
32
LifeVantage
LFVN
$81.1M
| $988K | 0.99% |
75,508
| – | – |
|
33
Pfizer
PFE
$143B
| $981K | 0.99% |
40,459
-375
| -0.9% | -$8.74K |
|
34
Apple
AAPL
$4.54T
| $954K | 0.96% |
4,650
| – | – |
|
35
AtriCure
ATRC
$1.92B
| $954K | 0.96% |
29,102
-798
| -3% | -$25.9K |
|
36
Gilead Sciences
GILD
$162B
| $924K | 0.93% |
8,333
-2,000
| -19% | -$213K |
|
37
SkyWater Technology
SKYT
| $898K | 0.9% |
91,250
-13,000
| -12% | -$105K |
|
38
AT&T
T
$159B
| $878K | 0.88% |
30,342
-1,250
| -4% | -$34.4K |
|
39
Ciena
CIEN
$53.4B
| $785K | 0.79% |
9,650
-4,500
| -32% | -$323K |
|
40
Codexis
CDXS
$151M
| $761K | 0.77% |
312,000
-6,800
| -2% | -$15.9K |
|
41
Merck
MRK
$322B
| $693K | 0.7% |
8,750
-1,750
| -17% | -$139K |
|
42
Butterfly Network
BFLY
$1.89B
| $591K | 0.59% |
295,260
+20,260
| +7% | +$46.5K |
|
43
US Bancorp
USB
$98.2B
| $591K | 0.59% |
13,050
-200
| -2% | -$8.41K |
|
44
Castle Biosciences
CSTL
$855M
| $572K | 0.57% |
27,995
-5,970
| -18% | -$111K |
|
45
ANI Pharmaceuticals
ANIP
$1.8B
| $551K | 0.55% |
8,441
| – | – |
|
46
OptimizeRx
OPRX
$114M
| $528K | 0.53% |
39,096
-4,500
| -10% | -$49.2K |
|
47
Verizon
VZ
$195B
| $511K | 0.51% |
11,808
| – | – |
|
48
Apyx Medical
APYX
$173M
| $511K | 0.51% |
227,000
+21,500
| +10% | +$30.3K |
|
49
Viatris
VTRS
$20.4B
| $508K | 0.51% |
56,878
-3,000
| -5% | -$25.4K |
|
50
NXP Semiconductors
NXPI
$57.8B
| $503K | 0.51% |
2,300
| – | – |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
FTEA
WT
BAM
Perkins Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Perkins Capital Management held 87 positions worth $99.5M, up 4.9% from $94.8M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Perkins Capital Management withdrew a net $4.26M in Q2 2025, closing 4 positions and reducing 44 holdings. Its most notable exit was Cantaloupe, an estimated $1.85M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 62% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Perkins Capital Management opened a new position in Inogen worth $1.04M.
- Perkins Capital Management's largest Q2 2025 buy was Inogen: 148,050 shares worth $1.04M.
- Perkins Capital Management added most to Perion Network in Q2 2025, an estimated $700K increase.
- Perkins Capital Management's biggest Q2 2025 reduction was Exagen, cutting an estimated $1.16M.
- Perkins Capital Management fully exited Cantaloupe in Q2 2025, selling an estimated $1.85M.
- Perkins Capital Management's ten largest holdings make up 45% of its $99.5M portfolio in Q2 2025.
- Perkins Capital Management opened 5 new positions and closed 4 in Q2 2025.
- Perkins Capital Management's portfolio value rose 4.9% quarter-over-quarter to $99.5M.
Based on Perkins Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.